摘要
目的:了解厂家药品说明书与其他用药参考资料用药信息表达的差异,为规范药品信息的表达提供参考,保障用药安全。方法:从20大类药物中每类挑选2～3种常用药物,收集其厂家药品说明书及其他常用参考资料(局颁说明书、《用药须知》、《新编药物学》和《中国医师药师临床用药指南》)中"适应证"、"禁忌"、"慎用"3项相关信息并进行比较、分析。结果与结论:与厂家药品说明书比较,其他资料中3项信息的表达均以《新编药物学》差异最大,其中尤以"禁忌"项内容表达的差异最大,须进行规范。
OBJECTIVE： To understand the difference of drug information between the drug manufacturer＇ s instructions and other dug references, and to provide reference to standardizing the drug information to ensure drug safety. METHODS： Among 20 categories, 2-3 kinds of common drugs were selected. The indications, contraindications and caution of drug manufacturer＇ s instruc- tions and the common references （instructions issued by SFDA, CHP. Clinical Guide, New Pharmacology, Clinical Medication Guideline for Chinese Physicians） were collected and compared. RESULTS ＆ CONCLUSIONS： Compared with drug manufacturer＇s instructions, the largest differences of 3 items were found in New Pharmacology, especially contraindications item. The difference should be regulated.
出处
《中国药房》
CAS
CSCD
2013年第5期476-478,共3页
China Pharmacy
关键词
厂家药品说明书
用药信息
调查
适应证
禁忌
慎用
Drug manufacturer＇s instructions
Drug information
Investigation
Indications
Contraindications
Caution
